Core Viewpoint - PomDoctor Ltd. is facing a class action lawsuit due to allegations of securities law violations, including misleading statements and undisclosed fraudulent activities [1][3]. Group 1: Class Action Details - The class action is on behalf of investors who purchased PomDoctor securities between October 9, 2025, and December 11, 2025, with a deadline for filing a lead plaintiff motion set for April 6, 2026 [1]. - Investors can contact attorney Lesley F. Portnoy for legal rights discussions and case evaluations [2]. Group 2: Allegations Against PomDoctor - The complaint alleges that PomDoctor was involved in a fraudulent stock promotion scheme that included misinformation on social media and impersonation of financial professionals [3]. - It is claimed that insiders used offshore accounts to facilitate the dumping of shares during a price inflation campaign, and that the company's public statements omitted critical information regarding false rumors and artificial trading activity [3]. Group 3: Stock Performance Impact - PomDoctor's share price dropped significantly from approximately $0.50 per share on December 10, 2025, to about $0.38 per share on December 11, 2025, marking a decline of roughly $0.12 per share or approximately 24% in one trading session [4]. - This decline was attributed to increased volatility and selling pressure amid investor concerns about the company's financial performance and valuation [4].
Portnoy Law Firm Announces Class Action on Behalf of PomDoctor Ltd. Investors